Pharming Group N.V. (PHAR) stock
PHARNasdaqPharmaceutical PreparationsFiscal year ends December 31
$12.48+0.42 (+3.51%)
Close on Nov 18, 2026Market cap $875.92MP/E 312.1Yield –
Pharming gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
For fiscal 2025 it was $330.63M, up 26.3% from the year before. The highest annual figure on record is $330.63M in fiscal 2025.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $330.63M | +26.3% |
| FY2024 | Dec 31, 2024 | $261.80M | +18.9% |
| FY2023 | Dec 31, 2023 | $220.10M | +17.0% |
| FY2022 | Dec 31, 2022 | $188.06M | +5.8% |
| FY2021 | Dec 31, 2021 | $177.73M | -5.8% |
| FY2020 | Dec 31, 2020 | $188.64M | +14.0% |
| FY2019 | Dec 31, 2019 | $165.46M | – |
See a number that looks wrong?